These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 23024649)

  • 1. PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.
    Peyrou M; Ramadori P; Bourgoin L; Foti M
    PPAR Res; 2012; 2012():757803. PubMed ID: 23024649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.
    Portius D; Sobolewski C; Foti M
    PPAR Res; 2017; 2017():7058424. PubMed ID: 28167956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases.
    Kim IS; Silwal P; Jo EK
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease.
    Choudhary NS; Kumar N; Duseja A
    J Clin Exp Hepatol; 2019; 9(6):731-739. PubMed ID: 31889755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
    Latruffe N; Vamecq J
    Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
    Yessoufou A; Wahli W
    Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology and therapeutic applications of peroxisome proliferator- activated receptors.
    Menendez-Gutierrez MP; Roszer T; Ricote M
    Curr Top Med Chem; 2012; 12(6):548-84. PubMed ID: 22242855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases.
    Monsalve FA; Pyarasani RD; Delgado-Lopez F; Moore-Carrasco R
    Mediators Inflamm; 2013; 2013():549627. PubMed ID: 23781121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARs in liver physiology.
    Berthier A; Johanns M; Zummo FP; Lefebvre P; Staels B
    Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166097. PubMed ID: 33524529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages
    Lefere S; Puengel T; Hundertmark J; Penners C; Frank AK; Guillot A; de Muynck K; Heymann F; Adarbes V; Defrêne E; Estivalet C; Geerts A; Devisscher L; Wettstein G; Tacke F
    J Hepatol; 2020 Oct; 73(4):757-770. PubMed ID: 32360434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of peroxisome proliferator-activated receptors in the regulation of bile acid metabolism.
    Sun Y; Zhang L; Jiang Z
    Basic Clin Pharmacol Toxicol; 2024 Mar; 134(3):315-324. PubMed ID: 38048777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD).
    Qiu YY; Zhang J; Zeng FY; Zhu YZ
    Pharmacol Res; 2023 Jun; 192():106786. PubMed ID: 37146924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y
    Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of peroxisome proliferator-activated receptors in healthy and diseased eyes.
    Escandon P; Vasini B; Whelchel AE; Nicholas SE; Matlock HG; Ma JX; Karamichos D
    Exp Eye Res; 2021 Jul; 208():108617. PubMed ID: 34010603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel peroxisome proliferator-activated receptor responsive element-luciferase reporter mouse reveals gender specificity of peroxisome proliferator-activated receptor activity in liver.
    Ciana P; Biserni A; Tatangelo L; Tiveron C; Sciarroni AF; Ottobrini L; Maggi A
    Mol Endocrinol; 2007 Feb; 21(2):388-400. PubMed ID: 17158222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.
    Lamichane S; Dahal Lamichane B; Kwon SM
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview on biological mechanisms of PPARs.
    Kota BP; Huang TH; Roufogalis BD
    Pharmacol Res; 2005 Feb; 51(2):85-94. PubMed ID: 15629253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of bile acid and cholesterol metabolism by PPARs.
    Li T; Chiang JY
    PPAR Res; 2009; 2009():501739. PubMed ID: 19636418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.